Most Popular Stories
- FDA maps out long-awaited rules for the biosimilars business
- Mouse study triggers demands for a possible Alzheimer's treatment
- FDA approvals of 2011
- High price of failure drives drug development costs into the stratosphere
- Eisai loses panel vote on new Dacogen use
- GSK, Takeda say nay to in-house diagnostics units
Webinars
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Featured Jobs
-
Sr. Manager, Market Research Job
Celgene Corporation - Summit, NJ, US -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Director Marketing Communications
Bailey Search & Associates - Boston, MA
Events
- DCAT Week 2012
Mar 12-15 — New York City - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
- Retaining Brand Loyalty
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- Best Practices: ERP Vendor Reference-Checking
- Why the Next Big Fortune Could Be Made in… Curitiba?
- Meeting the Unmet Medical Needs and the Training Imperative
Cephalon CEO Frank Baldino
